Prakiraan rega marang bathi: impactbiomedinc.com (IBO)
The corporate structure of Impact BioMedical Inc (IBO) relies on early bioprotection patents and maintains a debt-free balance sheet. The company generates stable income through royalties from the licensing of mature medical solutions. Simultaneously, Impact BioMedical Inc (IBO) is implementing advanced biochemistry to develop antibacterial coatings. The company's future P/E metric reflects market expectations, where the 0.00 figure serves as the target valuation level for the asset.
Rincian metrik keuangan lan pasar impactbiomedinc.com (IBO)
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Impact BioMedical Inc|IBO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Impact BioMedical|IBO - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Impact BioMedical, Inc.|IBO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Impact BioMedical|Rasio cepet impactbiomedinc.com
- statistik bathi lan rasio pasar:
IBO - Bathi resik|Proyeksi bathi mangsa ngarep Impact BioMedical Inc|IBO - Koefisien rega marang bathi|Prakiraan rega marang bathi Impact BioMedical Inc|IBO - Rasio nilai perusahaan marang wutah bathi|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Impact BioMedical, Inc.|IBO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Impact BioMedical|IBO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan impactbiomedinc.com|IBO - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Impact BioMedical Inc
Analisis dhasar perusahaan:IBO Impact BioMedical Inc
The business stability of Impact BioMedical Inc (IBO) depends on the effective integration of biorobotics and the automation of intellectual property accounting. The company's expected P/E ratio compares current market capitalization with projected earnings, allowing investors to assess the justification of the market premium through the lens of future income, where an inflated multiple signals correction risks should the pace of technological growth slow.
Pesaing Impact BioMedical Inc
Rega marang bathi mangsa ngarep Haleon (HLN)|KVUE - Rasio prakiraan rega marang bathi|Verona Pharma Corp - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep MENS (Jyong Bio)|Ligand Pharmaceuticals - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi AMRX (amneal.com)|PRGO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Alvotech S.A. (ALVO)|Rega marang bathi mangsa ngarep Liquidia Technologies|GLPG: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ANIP|Kapitalisasi marang proyeksi bathi mannkindcorp.com|Rega marang bathi mangsa ngarep Amphastar Pharmaceuticals, Inc. AMPH|PCRX - Prakiraan rega marang bathi|SPRY - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake TBPH|AQST: Pangali Forward P/E|scPharmaceuticals (SCPH) - Pangali Forward P/E|TECX (Tectonic Therapeutic Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Tonix Pharma (TNXP)|Prakiraan rega marang bathi SXTC (China SXT Pharmaceuticals)|Rasio kapitalisasi marang bathi mangsa ngarep EPRX|BioHarvest Sciences - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi EXOZ|Oramed Pharma - Pangali Forward P/E|ENTX: Rega marang bathi mangsa ngarep|HYFT: Pangali Forward P/E|ABVC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Cumberland Pharmaceuticals|Rasio prakiraan rega marang bathi quantumbiopharma.com QNTM|Rega marang bathi mangsa ngarep FibroGen (FGEN)|Prakiraan rega marang bathi Telomir Pharmaceuticals Inc TELO|Pangali Forward P/E RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. (SNYR) - Rasio prakiraan rega marang bathi|Rallybio Corp. - Pangali Forward P/E|LEXX (Lexaria Bioscience) - Rasio rega marang bathi mangsa ngarep|PULM: Pangali Forward P/E|PTHL - Kapitalisasi marang proyeksi bathi|APM (Aptorum Group Ltd) - Pangali Forward P/E|Prakiraan rega marang bathi Lyra Therapeutics Inc (LYRA)|Pangali Forward P/E TNFA|Pangali Forward P/E cbdmd.com (YCBD)|Rega marang bathi mangsa ngarep PainReform PRFX|Altamira Therapeutics Ltd - Rega marang bathi mangsa ngarep|LIPO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi OPTN (OptiNose Corp)|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Petros Pharmaceuticals, Inc.|Rasio rega marang bathi mangsa ngarep QLI (Qilian International Holding Group)|Pangali Forward P/E SLRN|Prakiraan rega marang bathi TFF Pharmaceuticals, Inc TFFP
